semaglutide and cardiovascular outcomes in obesity patients with and prevalent heart failure: a prespecified analysis of the SELECT trial VisualAbstract: Semaglutide and Cardiovascular Outcomes
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29

























